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ABSTRACT
Recent development of analytical methods for lipid hy-
droperoxides and preparation of highly pure lipid hydro-
peroxides have revealed the important new pathophysi-
ological roles of oxidized phospholipids. Generation of 
reactive oxygen species and subsequent oxidative stress 
leads to random oxidation of membrane phospholipids. 
However, recent studies have reported that anionic phos-
pholipid molecules such as phosphatidylserine (PS) and 
cardiolipin are preferentially oxidized during apoptosis, 
resulting in efficient apoptosis execution and apoptotic 
cell clearance by phagocytes. This review is exclusively 
focused on selective production of oxidized PS (oxPS) 
during apoptosis as well as the novel roles of oxPS under 
pathophysiological conditions. 
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From the 80s to the 90s, a number of studies on roles of 
lipid peroxidation in a variety of diseases and/or animal 
disease models were carried out.1–3 However, whether 
generation of lipid hydroperoxides resulted in or from 
diseases was usually argued. It is assumed to be due to 
the absence of precise methods for analyzing lipid hy-
droperoxides at that time. Recent development of analyt-
ical methods using mass spectrometry4 as well as prepa-
ration of highly pure lipid hydroperoxides5 have revealed 
the following novel pathophysiological roles of oxidized 
phospholipids: specific epitopes of innate immunity re-
ceptors, modification of intracellular signal transduction, 
pro- and anti-inflammatory activities, enhancement of 
reactive oxygen species (ROS) generation, angiogenesis, 
calcification of atherosclerotic plaques, inhibition of 
acquired immunity and enhancement of blood coagula-
tion.6, 7 These roles of oxidized phospholipids mani-
fested in the above studies were predominantly related 
to those of oxidatively modified products of phosphsti-
dylcholine (PC), the most abundant phospholipid in the 
membrane. Phosphatidylserine (PS) is also known to 
be a preferential target of in vivo oxidation.8 The aim 
of this review is to exclusively focus on the production 
of oxidized phosphatidylserine (oxPS) and its biological 
activities.
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PROduCTiOn Of oxPS
It is well known that non-enzymatic oxidation of phos-
pholipids including PS in membranes can be initiated by 
free radicals or non-radical ROS under many pathologi-
cal conditions.6 Here, selective, but not random oxida-
tion of negatively charged phospholipids such as PS and 
cardiolipin (CL) is described in detail.
Asymmetric distribution of phospholipids in plas-
ma membranes
Bretscher9 has first postulated the concept of “phos-
pholipid asymmetry” suggesting that phospholipids in 
plasma membrane are distributed asymmetrically be-
tween two leaflets. Indeed, in normal cells the choline-
containing phospholipids, PC and sphingomyelin, reside 
mainly in the outer leaflet of plasma membrane, whereas 
the aminophospholipids, PS and, to a lesser extent, phos-
phatidylethanolamine (PE), are confined to the inner 
leaflet.10 It seems that at least three lipid translocators 
are related to maintain this asymmetry. ATP-dependent 
flippases, members of type 4 P-type ATPases, also re-
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ferred to as aminophospholipid translocases, are specific 
for aminophospholipids, with a preference for PS over 
PE, and catalyze the inward translocation of aminophos-
pholipids.11 Another ATP-dependent translocator flop-
pases, members of ATP-binding cassette transporters, 
catalyze the efflux of phospholipids from the inner to the 
outer leaflet with little selectivity for polar head group 
of the phospholipids.12 Energy-independent scramblases 
are non-selective and catalyze bidirectional transbilayer 
movement of phospholipids Ca2+-dependently but ATP-
independently.13, 14
 PS externalization to the cell surface commonly 
found in apoptotic cells is likely to be associated with 
the inhibition of flippases as well as the activation of 
scramblases in the plasma membrane.15
 
oxPS generation in apoptotic cells
There is accumulating evidence showing that apoptosis 
induced by various stimuli in a number of different cell 
types is accompanied by preferential oxidation of PS.8, 
16–21 Furthermore, it has been reported that oxidation 
and externalization of PS almost simultaneously occur 
during apoptosis.22, 23
 As the source of oxidizing equivalents required for 
redox catalysis of PS oxidation was not identified, we 
determined which kind of ROS oxidized PS in the cells 
undergoing apoptosis.24 We used H2O2-resistant HP100 
cells derived from HL-60 cells, which expressed cata-
lase (CAT) 2.5 times more than HL-60 cells but con-
tained the same levels of primary antioxidant enzymes 
(glutathione peroxidase and superoxide dismutase) and 
apoptosis-related proteins (Bcl-2 and Bax) as HL-60 
cells. HP100 cells but not HL-60 cells exerted a higher 
resistance to apoptosis induced by anti-cancer reagent 
melphalan (Mel). This resistance to Mel-induced apopto-
sis in HP100 cells was abolished by pretreatment with a 
CAT inhibitor 3-amino-1,2,4-triazole (3-AT), suggesting 
that overexpression of CAT in HP100 cells was mainly 
responsible for their resistance to Mel-induced apoptosis. 
Treatment of HL-60 cells with Mel induced ROS pro-
duction in the cells. However, no increase in ROS gen-
eration in HL-60 cells co-treated with exogenous CAT 
following Mel treatment. On the other hands, there was 
no ROS generation in naïve HP100 cells both before and 
after Mel treatment although Mel caused ROS produc-
tion in HP100 cells pretreated with 3-AT as well. Thus, 
it was suggested that ROS generated in the cells treated 
with Mel is predominantly H2O2. Mel induced also PS 
oxidation and externalization as well as cytochrome c (cyt 
c) from mitochondria into cytosol in HL-60 cells but not 
HP100 cells. In addition, CAT inhibition by 3-AT re-
stored the sensitivity of HP100 cells to PS oxidation and 
externalization after Mel exposure. This suggested that 
Mel-induced H2O2 indeed plays a pivotal role in imple-
mentation of apoptosis (PS oxidation, PS externalization 
and cyt c release) as a required messenger.
 
The presence of oxPS on the apoptotic cell surface 
We demonstrated for the first time that oxPS exists both 
within and on the surface of apoptotic cells.25
 To determine PS on the cell surface, Jurkat cells fol-
lowing anti-Fas antibody treatment were labeled with 
membrane-impermeable fluorescamine, a probe for 
visualizing lipids that contain primary amino groups. 
Their total lipids were extracted and subjected to two-
dimensional high-performance thin-layer chromatog-
raphy (HPTLC). Thereafter the HPTLC plate was first 
sprayed with N,N,N’,N’-tetramethyl-p-phenylenediamine 
dihydrochloride (TMPD) to detect the oxidation of PS 
and then exposed to UV lights to determine externalized 
PS. Since fluorescamine and TMPD interact with a pri-
mary amine in the polar head group and hydroperoxide 
in acyl residue of oxPS, respectively, we can detect both 
externalization and oxidation of PS on the same HPTLC 
plate, i.e., prove the presence of oxPS on the surface of 
the cells. Additionally, to determine PS unbound to fluo-
rescamine, i.e., PS within the cells, the same HPTLC 
plate was sprayed with ninhydrin, another probe that 
reacts with primary amino groups. The above methods 
enabled direct detection of oxPS both within and on the 
surface of cells on the same HPTLC plate. The experi-
ments using the above methods suggested that treatment 
of Jurkat cells with anti-Fas antibody increased oxPS 
within the cells and caused oxPS to appear on the cell 
surface.
 
The mechanisms underlying oxidation of PS during 
apoptosis
It is considered that a potential mechanism underly-
ing selective oxidation of CL and PS by H2O2 during 
apoptosis relies on the specific interactions between 
positively charged cyt c (net charge is +8e at neutral pH) 
and negatively charged phospholipids such as PS in the 
cytosolic leaflet of the plasma membrane and CL in the 
mitochondria.23, 26 Cyt c is a globular protein containing 
heme and its heme iron has 6 coordination bonds. In cyt 
c, heme iron has two axial bonds: one with His17 on the 
proximal side of heme and one with Met80 on the distal 
side.23 When cyt c binds to membrane PS or CL with 
electrostatic forces, hydrophobic interactions and hydro-
gen bonding, the protein globule is partially unfolded, 
likely leading to disruption of Fe-Met80 coordination 
bond followed by enhancement of reactivity of cyt c to 
ROS such as H2O2.23, 26 Cyt c seems to get peroxidase 
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activity by such conformational changes. Presumably, 
highly oxidized heme (compound I or II) and protein-
based tyrosyl radical formed in the presence of H2O2 in 
PS- or CL-activated peroxidase forms of cyt c can sub-
tract an electron from unsaturated acyl chains of PS or 
CL followed by the addition of oxygen and formation of 
oxPS (PSOOH) or oxCL (CLOOH), similar to peroxi-
dase reaction to cyclooxygenase (COX).23 Newly formed 
oxPS (PSOOH) or oxCL (CLOOH) may function as 
substrates for cyt c peroxidase activity and further prop-
agate lipid peroxidation, even in the absence of H2O2. 
In cell-free model experiments,27 cyt c-derived tyrosyl 
radical was measured by low-temperature electron para-
magnetic resonance spectroscopy in the presence of cyt 
c, phospholipid-containing liposomes and H2O2. The 
production of tyrosyl radical depended strongly on the 
presence of PS-containing liposomes, supporting the 
above hypothesis indirectly.
 It has been suggested that peroxidase activity of cyt 
c is closely related to PS oxidation and externalization 
as mentioned above. Therefore, we determined whether 
departure of cyt c from mitochondria is required for pro-
duction of oxPS as well as its externalization during Fas-
mediated apoptosis in Jurkat cells using two selective 
inhibitors of caspase-8 (Casp-8) and caspase-3 (Casp-
3) functioning upstream and downstream from mito-
chondria, respectively.28 As shown in Fig. 1, inhibition 
of Casp-8 reduced mitochondrial cyt c release into the 
cytosol (Fig. 1A), the amount of oxPS not only within 
but also on the surface of Jurkat cells (Fig. 1B), Casp-
3 activation, and apoptotic cell number after treatment 
with anti-Fas antibody. In contrast, selective inhibition 
of Casp-3 was unable to suppress cyt c release (Fig. 1A), 
and the amount of oxPS both within and on the surface 
of the cells after anti-Fas antibody (Fig. 1B) as expected, 
although it inhibited activation of Casp-3 and apopto-
sis. These results strongly suggested that mitochondrial 
event, especially cyt c departure from mitochondria 
plays a critical role in production of oxPS within the 
cells and subsequent its appearance on the cell surface 
during apoptosis.
 
Production of oxPS under pathological conditions 
(in vivo)
Pulmonary phospholipid peroxidation after inhalation 
exposure of mice to single-walled carbon nanotubes was 
identified in three relatively minor classes of anionic 
phospholipids, PS, CL and phosphatidylinositol (PI).29 
This non-random peroxidation of phospholipids coin-
cided with the accumulation of apoptotic cells in the 
lung. In another animal models of lung injury (hyperoxic 
acute lung injury30 and gamma-radiation-induced lung 
injury31), the preferential formation of oxPS and oxCL in 
the lung was also detected. These lung injuries were all 
accompanied by apoptotic cell accumulation in the lung.
 In mouse model of Alzheimer disease (AD), which 
showed aberrant expression of human myeloperoxidase 
in astrocytes, there was selective accumulation of two 
anionic phospholipid hydroperoxides, oxPS (PSOOH) 
and oxPI (PIOOH) in the brains.32 Furthermore, in post-
mortem brain samples from AD patients, accumulation 
of the same individual molecular species of oxPS and 
oxPI was observed.32 In addition to the above brain dis-
eases, it has been demonstrated that selective oxidation 
of CL and PS in rat cortical neurons is triggered during 
staurosporine-induced apoptosis.33
Fig. 1. Effect of caspase inhibitors on cyt c release into the cytosol (A) as well as oxidation of PS exposed to the cell surface (B) in Jurkat 
cells after treatment with anti-Fas antibody.28  aP < 0.01 versus control, bP < 0.01 versus anti-Fas antibody alone.
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 Total body irradiation to mice induced intestinal 
injury accompanied by apoptosis as well as selective ac-
cumulation of oxCL and oxPS in small intestines.34
 It has been reported that anti-phospholipid antibod-
ies in sera from patients with alcoholic liver disease 
(ALD) target apoptotic cells by specifically recognizing 
oxPS, suggesting the production of oxPS in ALD.35
BiOACTiviTieS Of oxPS
Role in apoptotic cell clearance 
It has been established that PS serves as a recognizable 
“eat-me” signal for phagocytes through its translocation 
from the inner to the outer leaflet of the plasma mem-
brane during apoptosis.36 However, oxPS also appears 
on the surface of apoptotic cells during apoptosis.25 
Therefore, it is important to determine whether oxPS 
on the surface of apoptotic cells enhances the recogni-
tion and engulfment of apoptotic cells by phagocytes. 
Several receptors for apoptotic cell uptake have been 
identified on the surface of the phagocytes. They include 
the lectins that bind altered sugars on apoptotic cells, 
CD36 (in conjunction with integrins alphaVbeta3 and 
alphaVbeta5) that binds thrombospondin, LRP1/CD91 
(in conjunction with calreticulin) that binds complement 
C1q, CD14 that binds intercellular adhesion molecule 3 
(ICAM3), and the scavenger receptors that bind oxidized 
LDL.37 Furthermore, PS is recognized either directly via 
receptors such as brain angiogenesis inhibitor 1 (BAI1), 
T-cell immunoglobulin- and mucin-domain-containing 
4 (TIM-4), TIM-1, and Stabilin-2 or indirectly via bridg-
ing molecules such as milk fat globule-EGF factor 8 
(MFG-E8), growth-arrest-specific 6 (Gas6), or protein 
S.37 MFG-E8 is expressed and secreted by professional 
phagocytes, associates with integrins alphaVbeta3/
alphaVbeta5 on phagocytes, and binds PS on apoptotic 
cells.38
 As for oxPS, it has been reported that the oxPS, but 
not non-oxidized PS, serves as a preferred ligand for 
class B scavenger receptor CD36-mediated phagocyto-
sis by macrophages.39 Moreover, it has been shown that 
MFG-E8 preferentially interacts with oxPS, and to a 
lesser extent, with non-oxidized PS.40 In another study,8 
liposomes containing oxPS inhibited phagocytosis of 
apoptotic cells more potently than non-oxidized PS. 
Furthermore, non-apoptotic cells treated with liposomes 
containing both oxPS and non-oxidized PS were more 
efficiently phagocytosed than cells treated with non-
oxidized PS alone.8
 Taken together, these findings indicate that oxPS 
may act in combination with naïve PS as an important 
signal on the cell surface to facilitate the recognition 
of apoptotic cells. In other words, oxPS is likely to en-
hance the clearance of apoptotic cells by phagocytes. In 
addition, it has been reported that oxPS acts as a “non-
enzymatic scramblase” to facilitate translocation of both 
PS and oxPS molecules into the cell surface.41
 
Anti-inflammatory activities 
Protection against endothelial barrier dysfunction 
and acute lung injury
The tight intercellular barrier of endothelial cell (EC) 
maintaining low permeability is adequately regulated by 
a counterbalance of barrier-protective and barrier-dis-
ruptive bioactive molecules in the circulation.42 Birukova 
et al. showed that oxidized 1-palmitoyl-2-arachidonoyl-
sn-glycero-3-phosphoserine (oxPAPS) potently protected 
pulmonary EC barrier function and induced the remod-
eling of pulmonary EC actin cytoskeleton.42 In that 
study, oxPAPS inhibited the increase in permeability in 
human pulmonary arterial EC induced by lipopolysac-
charide (LPS), a major component of the outer mem-
brane of Gram-negative bacteria. oxPAPS also attenuat-
ed neutrophil accumulation and myeloperoxidase activa-
tion in bronchoalveolar lavage fluid in mice treated with 
LPS (in vivo model of acute lung injury), and suppressed 
lung barrier dysfunction in the mice. Furthermore, ox-
PAPS diminished pulmonary EC barrier dysfunction 
induced by interleukin (IL)-6, an inflammatory mediator 
or thrombin, an edemagenic mediator. The protection 
by oxPAPS against thrombin-induced pulmonary EC 
barrier dysfunction was attributed to both attenuation 
of Rho-dependent pathway of endothelial contraction 
leading to hyperpermeability and stimulation of Rac-
mediated EC barrier recovery. These results suggest 
that oxPAPS potently suppresses endothelial barrier 
dysfunction induced by inflammatory and edemagenic 
agents in vitro and in vivo potentially due to attenuation 
of Rho signaling as well as stimulation of Rac signaling. 
Since the protective effect of oxPAPS is much more than 
that of oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-
3-phosphocholine (oxPAPC), it seems that negatively 
charged polar head group but not oxidized sn-2 residue 
of oxPAPS may play some important role in its protec-
tive ability although PAPS, non-oxidized form, shows 
no protective effects. 
 
Inhibition of LPS recognition by TLR4 
LPS is a potent activator of macrophages and a causal 
agent of endotoxin shock.43 LPS is well known to in-
duce production of pro-inflammatory mediators such 
as tumor necrosis factor-alpha (TNF-alpha), IL-1beta, 
IL-6, ROS and nitric oxide (NO), leading to death from 
endotoxin shock in animal models.44, 45 Moreover, it has 
been shown that LPS enhances cytokine and/or NO pro-
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duction in macrophages,46 microglial cells47 and ECs.48 
The process of these cellular responses involves recogni-
tion of LPS by Toll-like receptor (TLR) 4 on the surface 
of the host cells, followed by activation of nuclear factor 
(NF)-kappa B.49 TLR is a receptor family protein relat-
ed to innate immunity and to date, 12 functional TLRs 
have been identified in mice and 10 in humans.50 TLR4 
has now been established as the receptor for LPS. The 
activation of innate immunity response by LPS starts 
from the interaction of LPS with LPS-binding protein 
(LBP). LBP in the serum removes LPS from the outer 
membrane of the bacteria and delivers LPS to soluble 
CD14 (sCD14) and/or membrane-bound CD14 and then 
LPS bound to CD14 is transferred to TLR4-myeloid dif-
ferentiation 2 (MD-2) complex. The formation of dimer-
ic LPS/MD-2/TLR4 complex initiates the intracellular 
signaling.51
 According to a recent study,52 oxPAPS inhibited 
LPS-induced elevation of E-selectin mRNA in human 
umbilical vein endothelial cells (HUVECs), indicat-
ing that it acted as an antagonist on induction of TLR4 
downstream genes. oxPAPS prevented binding of LPS to 
LBP in an in vitro competitive assay. Moreover, oxPAPS 
formed complexes with sCD14 and prevented interaction 
of LPS with sCD14 in vitro.
 Taken together, it was suggested that oxPAPS binds 
to LBP and sCD14, thus preventing recognition of LPS 
via MD-2/TLR4 complex, leading to inhibition of LPS-
induced inflammatory reaction.  
 
Inhibition of respiratory burst
Neutrophils are recruited to inflamed sites upon infec-
tions and exert microbicidal activities. The assembly 
and activity of NADPH oxidase (NOX) are essential for 
neutrophil microbicidal activities. Neutrophils engulf in-
vading microbes and kill them by ROS such as hydroxyl 
radicals and hypochlorous acids derived from superox-
ide anions generated by NOX together with microbicidal 
peptides and proteases in phagolysosomes.53, 54 Neutro-
phil NOX (NOX2), also referred to as respiratory burst 
oxidase is a multicomponent enzyme system composed 
of membrane proteins (p22phox and gp91phox, which 
form cytochrome b558) and cytosolic proteins (p47phox, 
p67phox, p40phox and Rac2), which assemble at mem-
brane sites upon cell activation. The importance of 
this enzyme in host defenses is highlighted by the fact 
that loss of function mutations of NOX subunits cause 
chronic granulomatous disease in which the phagocyte 
enzyme is dysfunctional, leading to life-threatening bac-
terial and fungal infections. In contrast, excessive ROS 
generation can damage surrounding tissues. Thus, NOX 
activation and ROS production have to be tightly regu-
lated.
 It has been shown that ROS produced by activated 
neutrophils promotes oxPS production.18 Blüml et al. 
reported that oxPAPS inhibited ROS production in 
phorbol myristate acetate (PMA)- or formyl-methionyl-
leucyl-phenylalanine (FMLP)-stimulated neutrophils 
in a dose dependent manner.55 In contrast, unoxidized 
PAPS dose-dependently increased the production of 
ROS in neutrophils, suggesting that there is an oxidation 
state-dependent regulatory role of oxPS on neutrophil 
respiratory burst formation. oxPAPS did not inhibit up-
regulation of CD11b which is involved in adhesion of ac-
tivated neutrophil to the endothelium, or phagocytosis. It 
has been known that MAPK (ERK1/2 and p38) are ac-
tivated during respiratory burst and there is involvement 
of these kinases in the production of ROS.56 However, 
oxPAPS did not inhibit activation of ERK1/2 and p38 in 
neutrophils stimulated with either PMA or FMLP.
 Taken together, it was shown that oxPAPS inhib-
ited respiratory burst in neutrophils induced by various 
stimuli without inhibiting MAPK activation.
 
Atherogenic activities 
Induction of VEGF via UPR
Endoplasmic reticulum (ER) is the site for proper fold-
ing of newly synthesized proteins and formation of 
three-dimensional conformation of proteins, and only 
proteins assured of quality in ER are released into the 
secretary pathway. ER stress induced by hypoxia, nutri-
ent deprivation, acidosis and certain chemicals disturbs 
the protein quality control leading to accumulation of 
the incorrect folded proteins in ER, and this triggers 
the activation of the following three ER transmembrane 
proteins, which generate an adaptive response called the 
unfolded protein response (UPR): inositol-requiring en-
zyme 1 (IRE1), double-stranded RNA-activated protein 
kinase (PKR)-like ER kinase (PERK) and activating 
transcription factor-6 (ATF6).57 The activation of these 
transducer proteins triggers signaling cascades, which 
induce downstream an adaptive UPR via protein kinases 
and transcription factors. The PERK/eIF2alpha/ATF4 
and IRE1/ASK1/JNK cascades can trigger the induction 
of vascular endothelial growth factor (VEGF).58
 It has been shown that oxPAPS stimulates gene 
expression of well-characterized angiogenesis induc-
ers (VEGF, IL-8 and COX-2) in HUVECs.59 oxPAPS 
induced VEGF via activation of ATF4 branch of UPR 
in HUVECs.60 According to a recent report, VEGF 
induction by oxPAPS in ECs depended on microR-
NA-663 (miR-663).61 Given that miR-663 is required for 
oxPAPC-induced elevation of ATF4 and its target gene 
TRIB (tribbles pseudokinase),61 it is suggested that ox-
PAPS may also induce ATF4 and its downstream gene 
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VEGF in a miR-663-dependent manner, playing a role 
in angiogenesis especially in atherosclerotic plaques.
Procoagulation 
Protein C is a vitamin-K dependent anti-coagulant 
serine protease serving as a negative feedback regula-
tor against coagulation.62 When thrombin generated by 
blood coagulation binds to thrombomodulin (TM) on 
the EC membrane, protein C is activated by thrombin-
TM complex to be an activated protein C (APC). This 
conversion is augmented by a specific receptor for pro-
tein C, endothelial cell protein C receptor. APC converts 
activated coagulation factors V (Va) and VIII (VIIIa) to 
the inactive forms by proteolysis with an APC cofactor 
protein S, resulting in inhibition of blood coagulation. 
In addition to its role in coagulation, APC decreases in-
flammatory responses by inhibition of nuclear transloca-
tion of NF-kappa B.62 
 Protein C inhibitor (PCI) is a serine protease inhibi-
tor belonging to the class of serpins.63 PCI, originally 
an inhibitor of APC, inactivates lots of other serine pro-
teases including blood coagulation factors, fibrinolytic 
enzymes, tissue kallikrein, and the sperm protease acro-
sin.64
 It has been shown that oxPAPS, PAPS and oxPAPE 
directly bind PCI and stimulate its inhibitory activity 
toward APC.64 Positively charged amino acids in the H-
helix of PCI were involved not only in heparin binding, 
but also in the binding of oxPAPS, PAPS and oxPAPE. 
 Given that PCI and annexin V, a protein binding to 
the head group of PS, were found to be endogenously 
colocalized in atherosclerotic plaques, it was suggested 
that oxPAPS in vivo could promote blood coagulation 
and thrombus formation as well as inflammation at sites 
of tissue injury by stimulating the inhibition of APC by 
PCI.
immunosuppressive activities
oxPAPS inhibited the proliferation of peripheral blood T 
cells induced by anti-CD3/CD28 monoclonal antibody, 
demonstrating a novel immunosuppressive molecule for 
adaptive immunity.65 In that study, oxPAPC prevented 
Fig. 2. Selective oxidation of PS and externalization of oxPS in apoptotic cells as well as recognition of oxPS on the cell surface by mac-
rophages. Its proposed mechanisms are indicated by bold arrows.
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the development of Th1-type responses, T cell prolifera-
tion and the induction as well as the effector phase of 
CD8+ effector cytotoxic T lymphocytes induced through 
stimulation via TCR/CD3 complex, although there were 
no data for oxPAPS. Furthermore, T cells activated in 
the presence of oxPAPC failed to proliferate in response 
to restimulation, a phenomenon called anergy. If oxPS 
functions similarly to oxPC, oxPS may also induce T 
cell anergy, resulting in avoiding overwhelming Th1-
driven immune responses at the inflammation sites. Fur-
ther examinations for oxPS will be required to resolve 
the above issues. 
 
COnCluding RemARKS
The oxidative stress associated with apoptosis results in 
the selective oxidation of PS in the cytoplasmic layer of 
the plasma membranes, followed by egress of oxPS to 
the surface of the apoptotic cells and effective recogni-
tion of oxPS by phagocytes. This is no longer than a 
mere non-specific oxidation of phospholipids, but seems 
to be a finely tuned system via non-random oxidation of 
PS for clearance of apoptotic cells by phagocytes to pre-
vent the inflammation (Fig. 2). oxPS has some biological 
activities such as anti-inflammatory activities, athero-
genic activities, and immunosuppressive activities other 
than the role in apoptotic cell clearance as mentioned 
above.
 In contrast, oxPC has more novel functions and is 
recognized as a lipid mediator. In the future, we have to 
examine using highly pure oxPS whether oxPS has the 
same functions as oxPC and furthermore detect undis-
covered biological activities of oxPS. In addition, it is 
also important to detect the specific receptor for oxPS in 
the phagocytes. 
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